Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM NEW
Shares outstanding
6,190,476
Total 13F shares
130,890
Share change
-124,853
Total reported value
$150,867
Price per share
$1.15
Number of holders
13
Value change
-$152,126
Number of buys
9
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q4 2022

As of 31 Dec 2022, Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 130,890 shares. The largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, HRT FINANCIAL LP, Mariner, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), Advisory Services Network, LLC, UBS Group AG, and MORGAN STANLEY. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.